Why Will NTC Succeed?


The Center has been organized using a novel, engineering-type decision and workflow model: Multiple approaches have been proposed to address each project, with go/no go decisions made based on achievement of milestones.

NanoTumor project leaders have founded more than 20 successful biotechnology companies, with a total market value of over two billion dollars, evidence of their ability to move discoveries to useful applications in the marketplace.

The intent of the NanoTumor Center to develop clinically useful platforms is also demonstrated by the strategic role played by clinicians from the Moores UCSD Cancer Center, and participants from major corporations such as:

  • GE Global Research
  • Nanogen Inc.
  • Honeywell - Automation & Control Solutions
  • Invitrogen Corporation
  • Enterprise Partners Venture Capital
  • Genentech Inc.

These companies will play an important role in evaluation the technologies.

TOOPAC-med
 

NTC Highlights

"US Senator Feinstein video address on cancer nanotechnology"

View

"Video: About the NanoTumor Center (3min)"

View

Multimedia Features

"Molecules for the Media: Nanotechnology--Science Fiction Meets Reality"

View

Calendar

"Nanotechnology Events"

  View

NTC News Feature

"Think Big with the Very Small..."

View